Market Overview

OLEO Appoints New Leadership Welcoming Skyler Bissell, Former Amazon and Boeing Employee, to the Role of Chief Executive Officer

Share:

OLEO Appoints New Leadership Welcoming Skyler Bissell, Former Amazon and Boeing Employee, to the Role of Chief Executive Officer

Rapid company growth and product demand at OLEO, Inc. calls for focused expansion and distinguished leadership naming former COO, Skyler Bissell to the role of Chief Executive Officer for his entrepreneurial vision for branding, marketing of consumer goods, and cannabis industry insight.

PR Newswire

SEATTLE, Aug. 27, 2018 /PRNewswire-PRWeb/ -- OLEO, Inc. the industry leader in micro-encapsulation technology for the production of water-soluble powdered cannabinoids, announced today that Skyler Bissell, former COO and co-founder at OLEO, will step up to the position of Chief Executive Officer, effective as of Monday, August 20th after a unanimous vote by OLEO's board of directors. Under Bissell's leadership OLEO will continue pursuing technological excellence and innovation in their lines of powdered CBD beverages designed for health-conscious active lifestyles.

By appointing fresh leadership with focus on products and branding, this new team structure will allow OLEO to expand quickly into new markets and most effectively promote the advantages of their powdered CBD beverages that are provided by their patent pending Micro-Encapsulation technology, the OLEO Process. As the new CEO, Bissell will leverage his background in marketing, data science, and business development to solve operational challenges and further develop OLEO as a leading brand of CBD products within today's rapidly growing cannabinoid market segment.

"This represents a significant step forward for OLEO and our ability to provide the unique advantages of our products to people across the country," says Skyler Bissell, CEO of OLEO, Inc. "Renewed focus on our lines of CBD-infused beverage powders creates a huge opportunity to reach new CBD users and educate them on the benefits of OLEO's micro-encapsulated, THC-free alternatives for the everyday active lifestyle."

Russell Stebbins, OLEO founder and former CEO will now command the role of Chief Products Officer to focus attention on expanding OLEO's existing and future product lines while ensuring excellence in quality control and product delivery. His expertise in innovation and R&D will ensure the company remains ahead of emerging ingredient trends and is able to continue bringing cutting edge products to market. Furthermore, Derick Anderson, OLEO co-founder and former CTO, will assume the role of COO to provide strong leadership to the company's consolidated operations.

The team is diligently working to further expand distribution and sales of the CBD-infused powdered beverages through direct focus on their three product lines: Coconut Water Mix, Rooibos Tea Mix, and Original Mix. These products are derived from natural ingredients, full of electrolytes, vitamins and minerals, and have zero artificial flavoring. OLEO powdered beverage mixes are the best drink choice for those seeking optimal hydration and natural health and wellness solutions pre, during and post activity.

About the Company

OLEO, Inc. is a biotechnology company thoughtfully designing fast-acting, water-soluble CBD products with purpose and intention for the active lifestyle community. OLEO offers a collection of powdered beverages infused with their active ingredient OleoCBD™, including an all-natural Coconut Water Mix, an antioxidant Rooibos Tea Mix, and a flavorless CBD powder called Original Mix. OleoCBD™ is created with a patent-pending micro-encapsulation technology that masks any bitter aftertaste and showcases its effects within 20 minutes. With a provisional patent for the powdered cannabinoid formulation method filed in 2014, OLEO, Inc. was founded quickly thereafter in 2015 and began mass producing micro-encapsulated cannabinoids for the hemp & cannabis markets by 2017. OLEO plays a tremendous role in the advancement of cannabinoid technology, testing standards and consumer product offerings, helping to make the cannabinoid and plant medicine industry more trusted, beneficial and approachable for all. Further clinical study results regarding micro-encapsulation to be released in 2018 as per the OLEO team's research influence and efforts.

MEDIA CONTACT: Brittany J. Confer | (814) 244 - 0653 | EMRLDpr(at)gmail.com

 

SOURCE OLEO, Inc.

View Comments and Join the Discussion!